Literature DB >> 30018130

Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma.

Shai Rosenberg1,2, Francois Ducray3,4,5, Agusti Alentorn6,7, Caroline Dehais7, Nabila Elarouci8, Aurelie Kamoun8, Yannick Marie6, Marie-Laure Tanguy9, Aurélien De Reynies8, Karima Mokhtari6,10, Dominique Figarella-Branger11,12, Jean-Yves Delattre13, Ahmed Idbaih14.   

Abstract

BACKGROUND: 1p/19q-codeleted anaplastic gliomas have variable clinical behavior. We have recently shown that the common 9p21.3 allelic loss is an independent prognostic factor in this tumor type. The aim of this study is to identify less frequent genomic copy number variations (CNVs) with clinical importance that may shed light on molecular oncogenesis of this tumor type.
MATERIALS AND METHODS: A cohort of 197 patients with anaplastic oligodendroglioma was collected as part of the French POLA network. Clinical, pathological, and molecular information was recorded. CNV analysis was performed using single-nucleotide polymorphism arrays. Computational biology and feature selection based on the random forests method were used to identify CNV events associated with overall survival and other clinical-pathological variables.
RESULTS: Recurrent chromosomal events were identified in chromosomes 4, 9, and 11. Forty-six focal amplification events and 22 focal deletion events were identified. Twenty-four focal CNV areas were associated with survival, and five of them were significantly associated with survival after multivariable analysis. Nine out of 24 CNV events were validated using an external cohort of The Cancer Genome Atlas. Five of the validated events contain a cancer-related gene or microRNA: CDKN2A deletion, SS18L1 amplification, RHOA/MIR191 copy-neutral loss of heterozygosity, FGFR3 amplification, and ARNT amplification. The CNV profile contributes to better survival prediction compared with clinical-based risk assessment.
CONCLUSION: Several recurrent CNV events, detected in anaplastic oligodendroglioma, enable better survival prediction. More importantly, they help in identifying potential genes for understanding oncogenesis and for personalized therapy. IMPLICATIONS FOR PRACTICE: Genomic analysis of 197 anaplastic oligodendroglioma tumors reveals recurrent somatic copy number variation areas that may help in understanding oncogenesis and target identification for precision medicine. A machine learning multivariable model built using this genomic information enables better survival prediction. © AlphaMed Press 2018.

Entities:  

Keywords:  Genomics; Glioma; Machine learning; Oligodendroglioma; Survival

Mesh:

Year:  2018        PMID: 30018130      PMCID: PMC6292528          DOI: 10.1634/theoncologist.2017-0495

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  29 in total

1.  Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells.

Authors:  Anastasia Y Kuznetsova; Katarzyna Seget; Giuliana K Moeller; Mirjam S de Pagter; Jeroen A D M de Roos; Milena Dürrbaum; Christian Kuffer; Stefan Müller; Guido J R Zaman; Wigard P Kloosterman; Zuzana Storchová
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.

Authors:  Jinghui Zhang; Kelly McCastlain; Hiroki Yoshihara; Beisi Xu; Yunchao Chang; Michelle L Churchman; Gang Wu; Yongjin Li; Lei Wei; Ilaria Iacobucci; Yu Liu; Chunxu Qu; Ji Wen; Michael Edmonson; Debbie Payne-Turner; Kerstin B Kaufmann; Shin-Ichiro Takayanagi; Erno Wienholds; Esmé Waanders; Panagiotis Ntziachristos; Sofia Bakogianni; Jingjing Wang; Iannis Aifantis; Kathryn G Roberts; Jing Ma; Guangchun Song; John Easton; Heather L Mulder; Xiang Chen; Scott Newman; Xiaotu Ma; Michael Rusch; Pankaj Gupta; Kristy Boggs; Bhavin Vadodaria; James Dalton; Yanling Liu; Marcus L Valentine; Li Ding; Charles Lu; Robert S Fulton; Lucinda Fulton; Yashodhan Tabib; Kerri Ochoa; Meenakshi Devidas; Deqing Pei; Cheng Cheng; Jun Yang; William E Evans; Mary V Relling; Ching-Hon Pui; Sima Jeha; Richard C Harvey; I-Ming L Chen; Cheryl L Willman; Guido Marcucci; Clara D Bloomfield; Jessica Kohlschmidt; Krzysztof Mrózek; Elisabeth Paietta; Martin S Tallman; Wendy Stock; Matthew C Foster; Janis Racevskis; Jacob M Rowe; Selina Luger; Steven M Kornblau; Sheila A Shurtleff; Susana C Raimondi; Elaine R Mardis; Richard K Wilson; John E Dick; Stephen P Hunger; Mignon L Loh; James R Downing; Charles G Mullighan
Journal:  Nat Genet       Date:  2016-10-24       Impact factor: 38.330

Review 3.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

Review 4.  Pharmacogenomics in the clinic.

Authors:  Mary V Relling; William E Evans
Journal:  Nature       Date:  2015-10-15       Impact factor: 49.962

5.  Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

Authors:  Michele Ceccarelli; Floris P Barthel; Tathiane M Malta; Thais S Sabedot; Sofie R Salama; Bradley A Murray; Olena Morozova; Yulia Newton; Amie Radenbaugh; Stefano M Pagnotta; Samreen Anjum; Jiguang Wang; Ganiraju Manyam; Pietro Zoppoli; Shiyun Ling; Arjun A Rao; Mia Grifford; Andrew D Cherniack; Hailei Zhang; Laila Poisson; Carlos Gilberto Carlotti; Daniela Pretti da Cunha Tirapelli; Arvind Rao; Tom Mikkelsen; Ching C Lau; W K Alfred Yung; Raul Rabadan; Jason Huse; Daniel J Brat; Norman L Lehman; Jill S Barnholtz-Sloan; Siyuan Zheng; Kenneth Hess; Ganesh Rao; Matthew Meyerson; Rameen Beroukhim; Lee Cooper; Rehan Akbani; Margaret Wrensch; David Haussler; Kenneth D Aldape; Peter W Laird; David H Gutmann; Houtan Noushmehr; Antonio Iavarone; Roel G W Verhaak
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

6.  Software for computing and annotating genomic ranges.

Authors:  Michael Lawrence; Wolfgang Huber; Hervé Pagès; Patrick Aboyoun; Marc Carlson; Robert Gentleman; Martin T Morgan; Vincent J Carey
Journal:  PLoS Comput Biol       Date:  2013-08-08       Impact factor: 4.475

7.  GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays.

Authors:  Ao Li; Zongzhi Liu; Kimberly Lezon-Geyda; Sudipa Sarkar; Donald Lannin; Vincent Schulz; Ian Krop; Eric Winer; Lyndsay Harris; David Tuck
Journal:  Nucleic Acids Res       Date:  2011-03-11       Impact factor: 16.971

8.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors:  Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 16.971

9.  Assessing the clinical utility of cancer genomic and proteomic data across tumor types.

Authors:  Yuan Yuan; Eliezer M Van Allen; Larsson Omberg; Nikhil Wagle; Ali Amin-Mansour; Artem Sokolov; Lauren A Byers; Yanxun Xu; Kenneth R Hess; Lixia Diao; Leng Han; Xuelin Huang; Michael S Lawrence; John N Weinstein; Josh M Stuart; Gordon B Mills; Levi A Garraway; Adam A Margolin; Gad Getz; Han Liang
Journal:  Nat Biotechnol       Date:  2014-06-22       Impact factor: 54.908

10.  Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas.

Authors:  Aurélie Kamoun; Ahmed Idbaih; Caroline Dehais; Nabila Elarouci; Catherine Carpentier; Eric Letouzé; Carole Colin; Karima Mokhtari; Anne Jouvet; Emmanuelle Uro-Coste; Nadine Martin-Duverneuil; Marc Sanson; Jean-Yves Delattre; Dominique Figarella-Branger; Aurélien de Reyniès; François Ducray
Journal:  Nat Commun       Date:  2016-04-19       Impact factor: 17.694

View more
  2 in total

1.  Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study.

Authors:  Louis Garnier; Chrystelle Vidal; Olivier Chinot; Elisabeth Cohen-Jonathan Moyal; Apolline Djelad; Charlotte Bronnimann; Lien Bekaert; Luc Taillandier; Jean-Sébastien Frenel; Olivier Langlois; Philippe Colin; Philippe Menei; Frédéric Dhermain; Catherine Carpentier; Aurélie Gerazime; Elsa Curtit; Dominique Figarella-Branger; Caroline Dehais; François Ducray
Journal:  Oncologist       Date:  2022-05-06       Impact factor: 5.837

2.  Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas.

Authors:  Giuseppe Broggi; Lucia Salvatorelli; Davide Barbagallo; Francesco Certo; Roberto Altieri; Elena Tirrò; Michele Massimino; Paolo Vigneri; Elia Guadagno; Grazia Maugeri; Velia D'Agata; Giuseppe Musumeci; Marco Ragusa; Giuseppe Maria Vincenzo Barbagallo; Daniela Russo; Rosario Caltabiano
Journal:  Cancers (Basel)       Date:  2021-04-26       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.